Klein, Brian D.,Lavreysen, Hilde,Pype, Stefan Maria Christiaan,Twyman, Roy E.,Van Osselaer, Nancy Eulalie Sylvain,White, H. Steven,Ceusters, Marc Andre,Cid-Nunez, Jose Maria,Trabanco-Suárez, Andrés Av
申请号：
AU2019208181
公开号：
AU2019208181A1
申请日:
2019.07.23
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2019208181A120190808.pdf#####ABSTRACT The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 receptor subtype 2 compound or a pharmaceutically acceptable salt or a solvate thereof, and a synaptic vesicle protein 2A ("SV2A") ligand.
